91 related articles for article (PubMed ID: 35858498)
1. Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A need for reconsideration?
Motahharynia A; Naghavi S; Shaygannejad V; Adibi I
Mult Scler Relat Disord; 2022 Oct; 66():104035. PubMed ID: 35858498
[TBL] [Abstract][Full Text] [Related]
2. Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: Case report and systematic review.
Anamnart C; Tisavipat N; Owattanapanich W; Apiwattanakul M; Savangned P; Prayoonwiwat N; Siritho S; Rattanathamsakul N; Jitprapaikulsan J
Mult Scler Relat Disord; 2022 Feb; 58():103414. PubMed ID: 35216789
[TBL] [Abstract][Full Text] [Related]
3. Optic Neuritis Following the BNT162b2 mRNA COVID-19 Vaccine in a Patient with Systemic Lupus Erythematosus Uncovering the Diagnosis of Neuromyelitis Optica Spectrum Disorders.
Shirah B; Mulla I; Aladdin Y
Ocul Immunol Inflamm; 2023 Aug; 31(6):1213-1215. PubMed ID: 35849732
[TBL] [Abstract][Full Text] [Related]
4. Therapy challenges for NMOSD in a patient with HIV.
Engels D; Havla J; Förderreuther S; Kümpfel T
Mult Scler; 2023 Dec; 29(14):1872-1875. PubMed ID: 37712413
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 vaccine response in Neuromyelitis Optica Spectrum Disorder.
Baba C; Kaya E; Ozcelik S; Ozdogar AT; Samadzade U; Cevik S; Calıskan C; Dogan Y; Ozakbas S
Clin Neurol Neurosurg; 2024 Mar; 238():108152. PubMed ID: 38382130
[TBL] [Abstract][Full Text] [Related]
6. Current and emerging therapeutics for neuromyelitis optica spectrum disorder: Relevance to the COVID-19 pandemic.
Abboud H; Zheng C; Kar I; Chen CK; Sau C; Serra A
Mult Scler Relat Disord; 2020 Sep; 44():102249. PubMed ID: 32526698
[TBL] [Abstract][Full Text] [Related]
7. A Case With New-Onset Neuromyelitis Optica Spectrum Disorder Following COVID-19 mRNA BNT162b2 Vaccination.
Caliskan I; Bulus E; Afsar N; Altintas A
Neurologist; 2022 May; 27(3):147-150. PubMed ID: 35184119
[TBL] [Abstract][Full Text] [Related]
8. Urosepsis Risk in Neuromyelitis Optica Spectrum Disorder Patients Administered Satralizumab.
Fujita R; Aratake Y; Nakata K; Fujii C; Kondo T
Intern Med; 2023 Nov; 62(22):3317-3320. PubMed ID: 37032080
[TBL] [Abstract][Full Text] [Related]
9. Treatment and Rehabilitation of a Patient with Neuromyelitis Optica Spectrum Disorder-Induced Complete Spinal Cord Injury Following COVID-19 Vaccination: A Case Report.
Han JS; Ryu SM; Lim YH; Kim AR; Jung TD
J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398485
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive therapy and COVID-19 infection in patients with NMOSD.
Choi UW; Ai X; Li H; Hao Y; Yao X; Guan Y
Immun Inflamm Dis; 2024 Jan; 12(1):e1128. PubMed ID: 38270296
[TBL] [Abstract][Full Text] [Related]
11. Comparing the consequences of COVID-19 vaccination between central nervous system (CNS) demyelinating diseases and other neurological disorders.
Yazdan Panah M; Vaheb S; Mokary Y; Afshari-Safavi A; Shaygannejad A; Ebrahimi N; Shaygannejad V; Mirmosayyeb O
Vaccine; 2024 Jun; ():. PubMed ID: 38886142
[TBL] [Abstract][Full Text] [Related]
12. Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era.
Hamdy SM; Abdel-Naseer M; Shehata HS; Shalaby NM; Hassan A; Elmazny A; Shaker E; Nada MAF; Ahmed SM; Hegazy MI; Mourad HS; Abdelalim A; Magdy R; Othman AS; Mekkawy DA; Kishk NA
Ther Clin Risk Manag; 2020; 16():759-767. PubMed ID: 32884277
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of COVID-19 infection in patients with Neuromyelitis optica spectrum disorder (NMOSD): A report from Iran.
Sahraian MA; Azimi A; Navardi S; Rezaeimanesh N; Naser Moghadasi A
Mult Scler Relat Disord; 2020 Sep; 44():102245. PubMed ID: 32512287
[No Abstract] [Full Text] [Related]
14. Human herpesvirus meningitis type 7 combined with neuromyelitis optica spectrum disorders: a case report.
Zhang W; Xing W; Huang Y; He J; Ling L
Acta Neurol Belg; 2024 Apr; 124(2):669-673. PubMed ID: 37635173
[No Abstract] [Full Text] [Related]
15. Prevalence of coronavirus disease 2019 in patients with neuromyelitis optica in Isfahan, Iran, and a review on recent reports and literature.
Etemadifar M; Salari M; Aminzade Z; Ebrahimi S; Tehrani-Fateh S
Curr J Neurol; 2021 Jul; 20(3):139-145. PubMed ID: 38011481
[No Abstract] [Full Text] [Related]
16. Recurrence of COVID-19 in a Patient With NMO Spectrum Disorder While Treating With Rituximab: A Case Report and Review of the Literature.
Paybast S; Shahrab F; Hejazi SA
Neurologist; 2021 Nov; 26(6):281-283. PubMed ID: 34734909
[TBL] [Abstract][Full Text] [Related]
17. Teaching NeuroImage: Hypothalamic Involvement in Neuromyelitis Optica Spectrum Disorder in a Child.
Cote-Orozco JE; Vélez-Tirado N
Neurology; 2022 Sep; 99(12):535-536. PubMed ID: 35803718
[No Abstract] [Full Text] [Related]
18. Wernicke Encephalopathy as the First Presentation of Neuromyelitis Optica Spectrum Disorder With Horizontal Nerve Palsy.
Supahiah P; Thomas BHI; Zhen PC; Aris AM; Abdul-Jalil F; Din NM
J Neuroophthalmol; 2023 Dec; 43(4):e293-e295. PubMed ID: 34924530
[No Abstract] [Full Text] [Related]
19. Hypothalamic Dysfunction, Bilateral Vertical Gaze Palsy, and Psychiatric Symptoms in Neuromyelitis Optica Spectrum Disorders: A Case Report.
Luo W; Liu C; Zhong X; Wang Y; Qiu W
J Neuroophthalmol; 2024 Mar; 44(1):e164-e166. PubMed ID: 36412924
[No Abstract] [Full Text] [Related]
20. Is COVID-19 severity associated with reduction in T lymphocytes in anti-CD20-treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder?
Hoepner R; Kamm CP; Friedli C; Salmen A; Chan A
CNS Neurosci Ther; 2022 Jun; 28(6):971-973. PubMed ID: 35411701
[No Abstract] [Full Text] [Related]
[Next] [New Search]
